Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  Liver Diseases

  Free Subscription


Articles published in J Clin Oncol

Retrieve available abstracts of 61 articles:
HTML format

Single Articles


    June 2008
  1. SIEGEL AB , Cohen EI, Ocean A, Lehrer D, et al
    Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma.
    J Clin Oncol. 2008;26:2992-8.
    PubMed     Related articles    Abstract available


  2. SELL S , Leffert HL
    Liver cancer stem cells.
    J Clin Oncol. 2008;26:2800-5.
    PubMed     Related articles    Abstract available


  3. D'ANGELICA M , Fong Y, DeMatteo RP, Jarnagin WR, et al
    Hepatic arterial infusion chemotherapy for metastases from colorectal cancer: is it really the end of an era?
    J Clin Oncol. 2008;26:2788-9.
    PubMed     Related articles   


  4. ZHU XD , Zhang JB, Zhuang PY, Zhu HG, et al
    High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma.
    J Clin Oncol. 2008;26:2707-16.
    PubMed     Related articles    Abstract available


    May 2008
  5. POWER DG , Leonard GD
    Hepatic arterial infusion: a treatment at the "end of an era"?
    J Clin Oncol. 2008;26:2597-8.
    PubMed     Related articles   


  6. MALOGOLOWKIN MH , Katzenstein HM, Krailo M, Chen Z, et al
    Redefining the role of doxorubicin for the treatment of children with hepatoblastoma.
    J Clin Oncol. 2008;26:2379-83.
    PubMed     Related articles    Abstract available


  7. KRISHNAN G , D'Silva K, Al-Janadi A
    Cetuximab-related tumor lysis syndrome in metastatic colon carcinoma.
    J Clin Oncol. 2008;26:2406-8.
    PubMed     Related articles   


  8. PESTALOZZI BC , Gruttadauria S, Clavien PA
    Hepatic arterial infusion: the beginning of the combination era.
    J Clin Oncol. 2008;26:2231-2.
    PubMed     Related articles   


  9. KWEKKEBOOM DJ , de Herder WW, Kam BL, van Eijck CH, et al
    Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival.
    J Clin Oncol. 2008;26:2124-30.
    PubMed     Related articles    Abstract available


    April 2008
  10. GRUENBERGER B , Tamandl D, Schueller J, Scheithauer W, et al
    Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer.
    J Clin Oncol. 2008;26:1830-5.
    PubMed     Related articles    Abstract available


  11. TRAINA TA , Theodoulou M, Feigin K, Patil S, et al
    Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer.
    J Clin Oncol. 2008;26:1797-802.
    PubMed     Related articles    Abstract available


  12. BILCHIK AJ , Hecht JR
    Perioperative risks of bevacizumab and other biologic agents for hepatectomy: theoretical or evidence based?
    J Clin Oncol. 2008;26:1786-8.
    PubMed     Related articles   


  13. GAMBOA EO , Sawhney V, Lanoy RS, Haller NA, et al
    Widespread metastases after resection of noninvasive thymoma.
    J Clin Oncol. 2008;26:1752-5.
    PubMed     Related articles   


  14. ADAM R , Wicherts DA, de Haas RJ, Aloia T, et al
    Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality?
    J Clin Oncol. 2008;26:1635-41.
    PubMed     Related articles    Abstract available


    March 2008
  15. ARNAUD L , Schartz NE, Kerob D, Lebbe C, et al
    Transient sunitinib-induced coma in a patient with fibromyxoid sarcoma.
    J Clin Oncol. 2008;26:1569-71.
    PubMed     Related articles   


  16. LIEUW-A-FA M , Peringa J, Leeksma O, Terpstra W, et al
    Sepsis from liver abscesses in metastatic colorectal carcinoma after chemoimmunotherapy.
    J Clin Oncol. 2008;26:1381-2.
    PubMed     Related articles   


  17. YAO JC , Phan A, Hoff PM, Chen HX, et al
    Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b.
    J Clin Oncol. 2008;26:1316-23.
    PubMed     Related articles    Abstract available


    February 2008
  18. HAN HS , Park SR, Kim SY, Park YI, et al
    Tumor lysis syndrome after capecitabine plus cisplatin treatment in advanced gastric cancer.
    J Clin Oncol. 2008;26:1006-8.
    PubMed     Related articles   


  19. RAMANATHAN RK , Egorin MJ, Takimoto CH, Remick SC, et al
    Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group.
    J Clin Oncol. 2008;26:563-9.
    PubMed     Related articles    Abstract available


  20. JUDSON IR
    Imatinib for patients with liver or kidney dysfunction: no need to modify the dose.
    J Clin Oncol. 2008;26:521-2.
    PubMed     Related articles   


    January 2008
  21. CHAN HL , Tse CH, Mo F, Koh J, et al
    High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.
    J Clin Oncol. 2008;26:177-82.
    PubMed     Related articles    Abstract available


  22. THOMAS MB , Davila M, Abbruzzese JL
    Stemming the tide of hepatitis B virus related hepatocellular carcinoma?
    J Clin Oncol. 2008;26:172-4.
    PubMed     Related articles   


  23. TSE RV , Hawkins M, Lockwood G, Kim JJ, et al
    Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available


    December 2007
  24. MOCELLIN S , Pilati P, Lise M, Nitti D, et al
    Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?
    J Clin Oncol. 2007;25:5649-54.
    PubMed     Related articles    Abstract available


    November 2007
  25. COYNE JC , Palmer SC
    More claims about depression, immune function, and survival that exceed the evidence.
    J Clin Oncol. 2007;25:5328-9.
    PubMed     Related articles   


  26. KIM SG , Park EC, Park JH, Hahm MI, et al
    Initiation and discontinuation of complementary therapy among cancer patients.
    J Clin Oncol. 2007;25:5267-74.
    PubMed     Related articles    Abstract available


  27. CRUMP M , Gluck S, Tu D, Stewart D, et al
    Randomized Trial of High-Dose Chemotherapy With Autologous Peripheral-Blood Stem Cell Support Compared With Standard-Dose Chemotherapy in Women With Metastatic Breast Cancer: NCIC MA.16.
    J Clin Oncol. 2007;.
    PubMed     Related articles    Abstract available


    October 2007
  28. SALTZ LB , Rosen LS, Marshall JL, Belt RJ, et al
    Phase II Trial of Sunitinib in Patients With Metastatic Colorectal Cancer After Failure of Standard Therapy.
    J Clin Oncol. 2007;25:4793-9.
    PubMed     Related articles    Abstract available


  29. KULKE MH , Blaszkowsky LS, Ryan DP, Clark JW, et al
    Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer.
    J Clin Oncol. 2007;25:4787-92.
    PubMed     Related articles    Abstract available


  30. ADAM R , Aloia T, Levi F, Wicherts DA, et al
    Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy.
    J Clin Oncol. 2007;25:4593-602.
    PubMed     Related articles    Abstract available


  31. TOMLINSON JS , Jarnagin WR, DeMatteo RP, Fong Y, et al
    Actual 10-year survival after resection of colorectal liver metastases defines cure.
    J Clin Oncol. 2007;25:4575-80.
    PubMed     Related articles    Abstract available


  32. VAUTHEY JN
    Colorectal liver metastases: treat effectively up front and consider the borderline resectable.
    J Clin Oncol. 2007;25:4524-5.
    PubMed     Related articles   


  33. DAVIS MP , Shaiova LA, Angst MS
    When opioids cause pain.
    J Clin Oncol. 2007;25:4497-8.
    PubMed     Related articles   


    September 2007
  34. GARCIA-DONAS J , Rodriguez N, Jara C, Urioste M, et al
    Retrorectal cystic hamartoma as benign cause of CA 19-9 elevation.
    J Clin Oncol. 2007;25:4012-4.
    PubMed     Related articles   


  35. LIM HS , Ju Lee H, Seok Lee K, Sook Lee E, et al
    Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer.
    J Clin Oncol. 2007;25:3837-45.
    PubMed     Related articles    Abstract available


    July 2007
  36. GISH RG , Porta C, Lazar L, Ruff P, et al
    Phase III Randomized Controlled Trial Comparing the Survival of Patients With Unresectable Hepatocellular Carcinoma Treated With Nolatrexed or Doxorubicin.
    J Clin Oncol. 2007;25:3069-75.
    PubMed     Related articles    Abstract available


  37. MILLER AA , Murry DJ, Owzar K, Hollis DR, et al
    Phase I and Pharmacokinetic Study of Erlotinib for Solid Tumors in Patients With Hepatic or Renal Dysfunction: CALGB 60101.
    J Clin Oncol. 2007;25:3055-60.
    PubMed     Related articles    Abstract available


    June 2007
  38. GAO Q , Qiu SJ, Fan J, Zhou J, et al
    Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.
    J Clin Oncol. 2007;25:2586-93.
    PubMed     Related articles    Abstract available


  39. STEEL JL , Geller DA, Gamblin TC, Olek MC, et al
    Depression, immunity, and survival in patients with hepatobiliary carcinoma.
    J Clin Oncol. 2007;25:2397-405.
    PubMed     Related articles    Abstract available


  40. HOLDHOFF M , Wung PK, Petronis JD, Couzi R, et al
    Persistent positron emission tomography-positive liver lesions after successful chemotherapy in mediastinal seminoma.
    J Clin Oncol. 2007;25:2482-4.
    PubMed     Related articles   


  41. RAHMI G , Malka D, Tomasic G, Dromain C, et al
    Complete, long-standing regression of hepatocellular carcinoma after somatostatin analogue treatment.
    J Clin Oncol. 2007;25:e15-6.
    PubMed     Related articles   


    May 2007
  42. ECKARDT JR , von Pawel J, Pujol JL, Papai Z, et al
    Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer.
    J Clin Oncol. 2007;25:2086-92.
    PubMed     Related articles    Abstract available


  43. KHO VK , Chen WC
    Hepatocellular carcinoma presenting as radiculopathy.
    J Clin Oncol. 2007;25:1805-6.
    PubMed     Related articles   


    April 2007
  44. GIANTONIO BJ , Catalano PJ, Meropol NJ, O'dwyer PJ, et al
    Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.
    J Clin Oncol. 2007;25:1539-44.
    PubMed     Related articles    Abstract available


  45. KOKUDO N , Hasegawa K, Makuuchi M
    Control arm for surgery alone is needed but difficult to obtain in randomized trials for adjuvant chemotherapy after liver resection for colorectal metastases.
    J Clin Oncol. 2007;25:1299-300.
    PubMed     Related articles   


    March 2007
  46. SHARMA RA , Van Hazel GA, Morgan B, Berry DP, et al
    Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.
    J Clin Oncol. 2007;25:1099-106.
    PubMed     Related articles    Abstract available


  47. LIAPI E , Geschwind JF
    Transcatheter and ablative therapeutic approaches for solid malignancies.
    J Clin Oncol. 2007;25:978-86.
    PubMed     Related articles    Abstract available


  48. TIMMERMAN RD , Kavanagh BD, Cho LC, Papiez L, et al
    Stereotactic body radiation therapy in multiple organ sites.
    J Clin Oncol. 2007;25:947-52.
    PubMed     Related articles    Abstract available


  49. PRAT A , Peralta S, Cuellar H, Ocana A, et al
    Hepatic pneumatosis as a complication of an abdominal desmoid tumor.
    J Clin Oncol. 2007;25:897-8.
    PubMed     Related articles   


    February 2007
  50. MEYERS RL , Katzenstein HM, Malogolowkin MH
    Predictive value of staging systems in hepatoblastoma.
    J Clin Oncol. 2007;25:737.
    PubMed     Related articles   


    December 2006
  51. NONAMI A , Takenaka K, Harada N, Kono K, et al
    Primary hepatic lymphoma 1 year after resection of hepatocellular carcinoma.
    J Clin Oncol. 2006;24:5784-6.
    PubMed     Related articles   


  52. GENTILUCCI UV , Santini D, Vincenzi B, Fiori E, et al
    Chemotherapy-induced steatohepatitis in colorectal cancer patients.
    J Clin Oncol. 2006;24:5467.
    PubMed     Related articles   


    November 2006
  53. RUBIE C , Oliveira-Frick V, Rau B, Schilling M, et al
    Chemokine receptor CCR6 expression in colorectal liver metastasis.
    J Clin Oncol. 2006;24:5173-4.
    PubMed     Related articles   


  54. MCGINNIS KA , Fultz SL, Skanderson M, Conigliaro J, et al
    Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse.
    J Clin Oncol. 2006;24:5005-9.
    PubMed     Related articles    Abstract available


  55. PARK SM , Lim MK, Shin SA, Yun YH, et al
    Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study.
    J Clin Oncol. 2006;24:5017-24.
    PubMed     Related articles    Abstract available


  56. ALOIA T , Sebagh M, Plasse M, Karam V, et al
    Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.
    J Clin Oncol. 2006;24:4983-90.
    PubMed     Related articles    Abstract available


  57. PORTIER G , Elias D, Bouche O, Rougier P, et al
    Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial.
    J Clin Oncol. 2006;24:4976-82.
    PubMed     Related articles    Abstract available


  58. NORDLINGER B , Benoist S
    Benefits and risks of neoadjuvant therapy for liver metastases.
    J Clin Oncol. 2006;24:4954-5.
    PubMed     Related articles   


  59. ALBERTS SR
    Evolving role of chemotherapy in resected liver metastases.
    J Clin Oncol. 2006;24:4952-3.
    PubMed     Related articles   


    October 2006
  60. ROLDO C , Missiaglia E, Hagan JP, Falconi M, et al
    MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior.
    J Clin Oncol. 2006;24:4677-84.
    PubMed     Related articles    Abstract available


  61. SIEGEL-LAKHAI WS , Crul M, De Porre P, Zhang S, et al
    Clinical and pharmacologic study of the farnesyltransferase inhibitor tipifarnib in cancer patients with normal or mildly or moderately impaired hepatic function.
    J Clin Oncol. 2006;24:4558-64.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: